All In MedTech

FDA Clearance Tracker · P900066

PERFLUOROPROPANE

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Feb 25, 1993 (this decision)Source: openFDAMethods & limitations

PMAFirst of its product code

Decided

Feb 25, 1993

Approved

Time to decision

846 days

Received Nov 2, 1990. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P900066
Device name
PERFLUOROPROPANE
Applicant location
Plumsteadville, PA
Received
Nov 2, 1990
Decided
Feb 25, 1993
Decision
Approved
Supplements
13 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III
Regulation
21 CFR 886.4270
Specialty
Ophthalmology

Every decision under product code LPO

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code LPO (Gases used within eye to place pressure on detached retina).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Airgas Therapeutics, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.